These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2220195)

  • 21. Vaccination with Bordetella bronchiseptica vaccine on a farm with atrophic rhinitis: an evaluation of a field experiment.
    Bercovich Z; Oosterwoud RA
    Tijdschr Diergeneeskd; 1977 Apr; 102(8):485-94. PubMed ID: 857335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of atrophic rhinitis vaccines on the reaction of pigs to serological tests for brucellosis.
    Corbel MJ
    Vet Rec; 1985 Aug; 117(7):150. PubMed ID: 4049708
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccination against atrophic rhinitis: effect on clinical symptoms, growth rate and turbinate atrophy.
    Baalsrud KJ
    Acta Vet Scand; 1987; 28(3-4):305-11. PubMed ID: 3454542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse potency assay for Bordetella bronchiseptica bacterins.
    Goodnow RA; Lehr CD; Shade FJ; Wisecarver JL
    J Clin Microbiol; 1977 Oct; 6(4):337-9. PubMed ID: 914991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine efficacy for reducing turbinate atrophy and improving growth rate in piggeries with endemic atrophic rhinitis.
    Kabay MJ; Mercy AR; Lloyd JM; Robertson GM
    Aust Vet J; 1992 May; 69(5):101-3. PubMed ID: 1627085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of a Bordetella live vaccine on the occurrence and manifestation of atrophic rhinitis suum and the aerogenous infection burden in field strains of the agent].
    Ehser U; Mehlhorn G; Mietke H
    Dtsch Tierarztl Wochenschr; 1993 Sep; 100(9):355-9. PubMed ID: 8223236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Measures to be adopted in the prevention and treatment of atrophic rhinitis in piglets under field conditions (author's transl)].
    Bercovich Z; De Jong MF
    Tijdschr Diergeneeskd; 1977 Apr; 102(7):448-55. PubMed ID: 847733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of an atrophic rhinitis vaccine under controlled conditions.
    Voets MT; Klaassen CH; Charlier P; Wiseman A; Descamps J
    Vet Rec; 1992 Jun; 130(25):549-53. PubMed ID: 1496755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis.
    Petersen SK; Foged NT; Bording A; Nielsen JP; Riemann HK; Frandsen PL
    Infect Immun; 1991 Apr; 59(4):1387-93. PubMed ID: 1706320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of vaccines for atrophic rhinitis--a comparison of three challenge models.
    Magyar T; King VL; Kovács F
    Vaccine; 2002 Mar; 20(13-14):1797-802. PubMed ID: 11906767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epizootiological studies on porcine atrophic rhinitis. X. Study of the heat-labile exotoxin (HLT) of Pasteurella multocida in mice.
    Eliás B; Gergely P; Boros G; Varró R
    Acta Vet Hung; 1986; 34(3-4):137-43. PubMed ID: 2953198
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica.
    Rajeev S; Nair RV; Kania SA; Bemis DA
    Vet Microbiol; 2003 Jul; 94(4):313-23. PubMed ID: 12829385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the etiology of infectious atrophic rhinitis of swine. VI. Effect of vaccination against nasal establishiment of Bordetella bronchiseptica.
    Koshimizu K; Kodama Y; Ogata M; Kino T; Sanbyakuda S
    Nihon Juigaku Zasshi; 1973 Oct; 35(5):411-8. PubMed ID: 4800055
    [No Abstract]   [Full Text] [Related]  

  • 34. EpidemiologicaL studies on atrophic rhinitis in swine. IX. Investigations on the introduction of the disease.
    Eliás B
    Zentralbl Veterinarmed B; 1986 Feb; 33(1):60-7. PubMed ID: 3705800
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. bronchiseptica and toxigenic type AP. multocida.
    Sakano T; Okada M; Taneda A; Mukai T; Sato S
    J Vet Med Sci; 1997 Jan; 59(1):55-7. PubMed ID: 9035080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological potency testing of vaccines against progressive atrophic rhinitis.
    Oppling V; Kusch M; Rübmann P; Cussler K
    Dev Biol Stand; 1996; 86():339. PubMed ID: 8785979
    [No Abstract]   [Full Text] [Related]  

  • 37. Epizootiological studies on porcine atrophic rhinitis. VII. Study of the aetiology and the local immune response.
    Eliás B; Magyar T; Gergely P; Boros G; Varró R
    Zentralbl Veterinarmed B; 1985 Sep; 32(8):557-66. PubMed ID: 2933903
    [No Abstract]   [Full Text] [Related]  

  • 38. [The prevention of atrophic rhinitis of swine].
    Bilkei G
    Berl Munch Tierarztl Wochenschr; 1989 Apr; 102(4):109-11. PubMed ID: 2719633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrophic rhinitis in swine.
    Rutter JM
    Adv Vet Sci Comp Med; 1985; 29():239-79. PubMed ID: 3911757
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of turbinate lesions and nasal colonization by Bordetella bronchiseptica and Pasteurella multocida during long-term exposure of healthy pigs to pigs affected by atrophic rhinitis.
    Bäckström LR; Brim TA; Collins MT
    Can J Vet Res; 1988 Jan; 52(1):23-9. PubMed ID: 3349398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.